Scientific Industries, Inc. (SCND)
| Market Cap | 8.95M |
| Revenue (ttm) | 5.05M |
| Net Income (ttm) | -1.22M |
| Shares Out | 11.93M |
| EPS (ttm) | -0.11 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,780 |
| Average Volume | 2,793 |
| Open | 0.846 |
| Previous Close | 0.846 |
| Day's Range | 0.750 - 0.846 |
| 52-Week Range | 0.300 - 1.010 |
| Beta | 0.35 |
| RSI | 54.25 |
| Earnings Date | May 12, 2026 |
About Scientific Industries
Scientific Industries, Inc. engages in the design, manufacture, and marketing of standard benchtop laboratory equipment, weight and measurement, and bioprocessing products in the United States, Germany, and internationally. The company offers vortex mixers to mix the contents of test tubes, beakers, and other containers by placing such containers on a rotating cup or other attachments; various mixers and shakers, such as high-speed touch mixers, mixers with an integral timer, cell disruptors, bead beaters, microplate mixers, programmable vortex... [Read more]
Financial Performance
In 2025, Scientific Industries's revenue was $5.05 million, an increase of 5.35% compared to the previous year's $4.80 million. Losses were -$1.22 million, -81.07% less than in 2024.
Financial StatementsNews
Scientific Industries Earnings Call Transcript: Q3 2025
Q3 2025 saw record revenue, driven by strong sales in bioprocessing and new AI-driven product features. The company completed the Genie division divestiture and is focused on expanding its DOTS and VIVID platforms, despite ongoing market caution and selective capital spending.
Scientific Industries Announces Third Quarter 2025 Results And Launch of VIVID's New AI-Powered Feature
TORBAL DIVISION SALES UP 15% YTD LAUNCH OF VIVID'S FIRST AI-POWERED FEATURE SECOND GENERATION VIVID-ONE LAUNCH SCHEDULED FOR Q1 CY26
Scientific Industries to Host Third Quarter Fiscal Year 2025 Financial Results Investor Call on November 20, 2025
BOHEMIA, N.Y., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Scientific Industries, Inc. (OTCQB: SCND), a developer of digitally simplified bioprocessing products and vision-based pill counters, announced it will...
Scientific Industries Transcript: Lytham Partners Fall 2025 Investor Conference
The company has transformed into a digital and AI-focused life science innovator, divesting legacy assets to invest in pharmacy automation and bioprocessing. With strong financials, a robust product roadmap, and major industry partnerships, it targets rapid growth and leadership in AI-enabled scientific tools.
Scientific Industries to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025
BOHEMIA, N.Y., Sept. 18, 2025 (GLOBE NEWSWIRE) -- Scientific Industries, Inc. (OTCQB: SCND), a developer of digitally simplified bioprocessing products and vision-based pill counters, today announced ...
Scientific Industries Earnings Call Transcript: Q2 2025
Legacy Genie division sold, shifting focus to AI-driven life science and bioprocessing. Q2 revenue rose 66% sequentially but lagged year-over-year, with academic sales sharply down. R&D and commercial engagement remain strong despite industry headwinds.
Scientific Industries Reports Financial Results for Second Quarter of Fiscal Year 2025
TORBAL DIVISION SALES UP 11% SECURED $10 MILLION IN STRATEGIC DIVESTURE OF GENIE PRODUCT LINE VIVID AND BIOPROCESSING NEW PRODUCT AI ROADMAP ON TARGET
Scientific Industries to Host Second Quarter Fiscal Year 2025 Financial Results Investor Call on August 20, 2025
BOHEMIA, N.Y., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Scientific Industries, Inc. (OTCQB: SCND), a developer of digitally simplified bioprocessing products and vision-based pill counters, announced it will...
Scientific Industries Completes Strategic Refocus and Secures Proceeds of $10 million to Accelerate Growth of Two Data-Driven Business Platforms; Divests Genie® Division to OHAUS Corporation's affiliate Troemner, LLC
Realign priorities - AI-powered platforms to accelerate innovation and market leadership Driving transformation in pharmacy automation with VIVID's advanced solutions Advancing AI-powered biomanufactu...
Scientific Industries Transcript: Lytham Partners Spring 2025 Investor Conference
The company is advancing digital automation in life science labs, launching new AI-enabled products and expanding its bioprocessing platform to reduce experiment costs and increase data output. With a strong financial position and major industry validation, it targets rapid growth and break-even by 2027.
Scientific Industries to Participate in the Lytham Partners Spring 2025 Investor Conference on May 29, 2025
BOHEMIA, N.Y., May 27, 2025 (GLOBE NEWSWIRE) -- Scientific Industries, Inc. (OTCQB: SCND), a life sciences tool provider, and a developer of digitally simplified bioprocessing products, announced it w...
Scientific Industries Earnings Call Transcript: Q1 2025
Q1 2025 saw strong benchtop equipment sales and increased U.S. demand, but bioprocessing revenue declined due to funding delays and longer sales cycles. Despite macroeconomic headwinds, new financing, product launches, and a robust sales pipeline position the company for growth later in 2025.
Scientific Industries Reports Financial Results for First Quarter of Fiscal Year 2025
BENCHTOP LAB EQUIPMENT SALES UP 5% FIRST PEER-REVIEWED PUBLICATION ON COMPANY'S DOTS MPS BIOPROCESSING PLATFORM RECORD NUMBER OF BIOPROCESSING SALES OPPORTUNITIES Investor Call to be held Wednesday, M...
Scientific Industries to Host First Quarter Fiscal Year 2025 Financial Results Investor Call on May 14, 2025
BOHEMIA, N.Y., May 12, 2025 (GLOBE NEWSWIRE) -- Scientific Industries, Inc. (OTCQB: SCND), a life sciences tool provider, and a developer of digitally simplified bioprocessing products, announced it w...
Scientific Industries Secures New Funding to Advance its SBI Bioprocessing Division
BOHEMIA, N.Y., April 22, 2025 (GLOBE NEWSWIRE) -- Scientific Industries, Inc. (OTCQB: SCND), a life sciences tool provider, and a developer of digitally simplified bioprocessing products, announced to...
Scientific Industries Earnings Call Transcript: Q4 2024
Fiscal 2024 saw operational streamlining, new product launches, and strong bioprocessing growth, with a 24% sales increase and a robust pipeline for 2025. The company reduced costs, improved margins, and is positioned for further expansion as industry conditions recover.
Scientific Industries to Host Fiscal Year 2024 Financial Results Investor Call on April 1, 2025
BOHEMIA, N.Y., April 01, 2025 (GLOBE NEWSWIRE) -- Scientific Industries, Inc. (OTCQB: SCND), a life sciences tool provider, and a developer of digitally simplified bioprocessing products, announced it...
Scientific Industries Reports Financial Results for Fiscal Year Ended December 31, 2024 and Launches DOTS MPS for Cell Culture Biopharma Market
BIOPROCESSING OPERATIONS: 24% REVENUE GROWTH DRIVEN BY NEWLY LAUNCHED PRODUCTS OPERATIONAL EFFICIENCIES CUT TOTAL NET LOSSES BY 29% LAUNCHED NEW STATE OF THE ART VIVID WORKSTATION Investor Call to be ...
Scientific Industries Earnings Call Transcript: Q3 2024
Sales rebounded in core and new product lines, with Vivid Pill Counter up 50% sequentially and bioprocessing U.S. revenue up 61% year-to-date. Cost reductions improved EBITDA and productivity, while new product launches and major account wins position the company for future growth.
Scientific Industries Reports Third Quarter 2024 Financial Results
BIOPROCESSING OPERATIONS RECORDS 3 CONSECUTIVE QUARTERS OF REVENUE GROWTH OPERATIONAL EFFICIENCIES CUT QUARTER AND YTD NET LOSSES BY 46% AND 34% TWO MAJOR NEW PRODUCTS TO LAUNCH IN Q1 2025 Investor Ca...
Scientific Industries to Host Third Quarter 2024 Financial Results Investor Call on November 15, 2024
BOHEMIA, N.Y., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Scientific Industries, Inc. (OTCQB: SCND), a life sciences tool provider, and a developer of digitally simplified bioprocessing products, announced tod...
Scientific Industries to Present at the Craig-Hallum Bioprocessing Conference on September 19, 2024
Fireside Chat to be held at 12:30 p.m. Eastern Time BOHEMIA, NY / ACCESSWIRE / September 17, 2024 / Scientific Industries, Inc. (OTCQB:SCND), a life sciences tool provider, and a developer of digitall...
Scientific Industries Earnings Call Transcript: Q2 2024
Genie and Torbal product lines rebounded after industry disruptions, with rapid growth expected from the VIVID Workstation launch. Bioprocessing saw 16% sales growth and 20% EBITDA improvement in H1, driven by strong U.S. performance and cost savings, while the DOTS platform gained early industry endorsement.
Scientific Industries Reports Second Quarter 2024 Results
STRONG PIPELINE FOR BIOPROCESSING DOTS MPS & TORBAL VIVID PILL COUNTER OPERATIONAL EFFICIENCIES CUT QUARTER AND YTD NET LOSS BY 41% AND 28% NET CASH USED BY OPERATIONS REDUCED BY 33% Investor Call to ...
Scientific Industries to Host Second Quarter 2024 Financial Results Investor Call on August 15, 2024
Investor Call to be held at 11:00 AM Eastern Time BOHEMIA, NY / ACCESSWIRE / August 14, 2024 / Scientific Industries, Inc. (OTCQB:SCND), a life sciences tool provider, and a developer of digitally sim...